Time course of fibrillation and defibrillation thresholds after an intravenous bolus of amiodarone - An experimental study

Resuscitation

Volumn 61, Issue 1, 2004, Pages 83-89

  Tsagalou, Eleftheria P ^a   Anastasiou Nana, Maria I ^a   Charitos, Christos E ^a   Siafakas, Costantinos X ^a   Drakos, Stavros G ^a   Ntalianis, Argirios ^a   Terrovitis, John V ^a   Mavrikakis, Emmanuel M ^a   Doufas, Antonios ^a   Nanas, John N ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Amiodarona; Amiodarone; Defibrillation; Desfibrilaci n; Desfibrilha o; Fibrilaci n ventricular; Fibrilha o ventricular; Ventricular fibrillation

Indexed keywords

AMIODARONE; SODIUM CHLORIDE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; DIRECT CURRENT; DISEASE MODEL; DRUG INFUSION; EXPERIMENT; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; INJECTION; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; REFRACTORY PERIOD; SWINE; THORAX; TIME;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BLOOD PRESSURE; DIFFERENTIAL THRESHOLD; ELECTRIC COUNTERSHOCK; INJECTIONS, INTRAVENOUS; MYOCARDIAL ISCHEMIA; SWINE; TIME FACTORS; VENTRICULAR FIBRILLATION; VENTRICULAR FUNCTION, LEFT;

EID: 11144356609     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2003.12.003     Document Type: Article

References (36)

1. Kaski J.C., Girotti L.A., Messuti H., Rutitzky B., Rosenbaum M.B. Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone. Circulation. 64:1981;273-279.
2. Leak D. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient. Am. Heart J. 111:1986;456-462.
3. Helmy I., Herre J.M., Gee G.et al. Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias. J. Am. Coll. Cardiol. 12:1988;1015-1022.
4. Levine J.H., Massumi A., Scheinman M.M.et al. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. J. Am. Coll. Cardiol. 27:1996;67-75.
5. Scheinman M.M., Levine J.H., Cannom D.S.et al. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group. Circulation. 92:1995;3264-3272.
6. Marcus F.I., Fontaine G.H., Frank R., Grosgogeat Y. Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone. Am. Heart J. 101:1981;480-493.
7. Williams M.L., Woelfel A., Cascio W.E., Simpson R.J. Jr., Gettes L.S., Foster J.R. Intravenous amiodarone during prolonged resuscitation from cardiac arrest. Ann. Intern. Med. 110:1989;839-842.
8. Chapman J.R., Boyd M.J. Intravenous amiodarone in ventricular fibrillation. Br. Med. J. (Clin. Res. Ed.). 282(6268):1981;951-952.
9. Kudenchuk P.J., Cobb L.A., Copass M.K.et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. New Engl. J. Med. 341:1999;871-878.
10. Edwards K.E., Wenstone R. Successful resuscitation from recurrent ventricular fibrillation secondary to butane inhalation. Br. J. Anaesth. 84:2000;803-805.
11. Dorian P., Cass D., Schwartz B., Cooper R., Gelaznikas R., Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. New Engl. J. Med. 346:2002;884-890.
12. Lubbe W.F., McFadyen M.L., Muller C.A., Worthington M., Opie L.H. Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart. Am. J. Cardiol. 43:1979;533-540.
13. Arredondo M.T., Guillen S.G., Quinteiro R.A. Effect of amiodarone on ventricular fibrillation and defibrillation thresholds in the canine heart under normal and ischemic conditions. Eur. J. Pharmacol. 125:1986;23-28.
14. Marinchak R.A., O'Connor K.M., Friehling T.D., Kowey P.R. Acute electrophysiologic effects and antiarrythmic/antifibrillatory activity of intravenous amiodarone in a chronic feline infarction model. J. Cardiovasc. Pharmacol. 14:1989;389-395.
15. Zhou L., White C.M., Chen B.P., Chow M.S., Fan C., Kluger J. A comparison of the antifibrillatory effects of desethylamiodarone to amiodarone in a swine model. J. Cardiovasc. Pharmacol. 34:1999;440-445.
16. Chen B.P., White C.M., Fan C., Kluger J., Chow M.S. The effect of amiodarone on the ventricular fibrillation threshold. Pharmacotherapy. 19:1999;832-837.
17. Anastasiou-Nana M.I., Nanas J.N., Nanas S.N.et al. Effects of amiodarone on refractory ventricular fibrillation in acute myocardial infarction: experimental study. J. Am. Coll. Cardiol. 23:1994;253-258.
18. Nanas J.N., Anastasiou-Nana M.I., Margari Z.J., Karli J., Moulopoulos S.D. Redistribution of amiodarone in heart transplant recipients treated with the drug before operation. J. Heart Lung Transplant. 16:1997;387-389.
19. Nanas J.N., Mason J.W. Pharmacokinetics and regional electrophysiological effects of intracoronary amiodarone administration. Circulation. 91:1995;451-461.
20. Zhou L., Chen B.P., Kluger J., Fan C., Chow M.S. Effects of amiodarone and its active metabolite desethylamiodarone on the ventricular defibrillation threshold. J. Am. Coll. Cardiol. 31:1998;1672-1678.
21. Singh B.N., Venkatesh N., Nademanee K., Josephson M.A., Kannan R. The historical development. Prog. Cardiovasc. Dis. 31:1989;249-280.
22. Anastasiou-Nana M.I., Nanas J.N., Alexopoulos G.et al. Amiodarone concentration in human myocardium after rapid intravenous administration. Cardiovasc. Drugs Ther. 13:1999;265-270.
23. Beder S.D., Cohen M.H., BenShachar G. Time course of myocardial amiodarone uptake in the piglet heart using a chronic animal model. Pediatr. Cardiol. 19:1998;204-211.
24. Latini R., Connolly S.J., Kates R.E. Myocardial disposition of amiodarone in the dog. J. Pharmacol. Exp. Ther. 224:1983;603-608.
25. Venkatesh N., Somani P., Bersohn M., Phair R., Kato R., Singh B.N. Electropharmacology of amiodarone: absence of relationship to serum, myocardial, and cardiac sarcolemmal membrane drug concentrations. Am. Heart J. 112:1986;916-922.
26. Connolly S.J., Latini R., Kates R.E. Pharmacodynamics of intravenous amiodarone in the dog. J. Cardiovasc. Pharmacol. 6:1984;531-535.
27. Anderson K.P., Walker R., Dustman T.et al. Rate-related electrophysiologic effects of long-term administration of amiodarone on canine ventricular myocardium in vivo. Circulation. 79:1989;948-958.
28. Morady F., DiCarlo L.A. Jr., Krol R.B., Baerman J.M., de Buitleir M. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction. J. Am. Coll. Cardiol. 7:1986;148-157.
29. Charlier R. Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoreceptors. Br. J. Pharmacol. 39:1970;668-674.
30. Du X.J., Esler M.D., Dart A.M. Sympatholytic action of intravenous amiodarone in the rat heart. Circulation. 91:1995;462-470.
31. Charlier R., Deltour G., Baundine A., Chaillet F. Pharmacology of amiodarone, an anti-anginal drug with a new biological profile. Arzneimittelforschung. 18:1968;1408-1417.
32. Frame L.H. The effect of oral and acute intravenous amiodarone administration on ventricular defibrillation threshold using implanted electrodes in dogs. Pacing Clin. Electrophysiol. 12:1989;339-346.
33. Boriani G., Biffi M., Frabetti L., Maraschi M., Branzi A. High defibrillation threshold at cardioverter defibrillator implantation under amiodarone treatment: favorable effects of D,L-sotalol. Heart Lung. 29:2000;412-416.
34. Echt D.S., Black J.N., Barbey J.T., Coxe D.R., Cato E. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs: sodium channel block and action potential prolongation. Circulation. 79:1989;1106-1117.
35. Ruffy R., Schechtman K., Monje E., Sandza J. Adrenergically mediated variations in the energy required to defibrillate the heart: observations in closed chest, nonanesthetized dogs. Circulation. 73:1986;374-380.
36. Dorian P., Wang M., Davy I., Feindel C. Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model. Circulation. 83:1991;614-621.